Detalles de la búsqueda
1.
Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.
Bioinformatics
; 35(17): 2924-2931, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689715
2.
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.
Lancet Oncol
; 20(11): 1576-1586, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31582354
3.
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways.
Haematologica
; 103(12): 2069-2078, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29976738
4.
Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.
Bioinformatics
; 35(17): 3216, 2019 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31161200
5.
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.
Blood
; 117(15): 4076-84, 2011 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21310924
6.
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
Blood
; 116(6): 945-52, 2010 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20393129
7.
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy.
Int J Cancer
; 128(11): 2759-64, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20715110
8.
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens.
Blood
; 113(14): 3168-71, 2009 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19050308
9.
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.
J Mol Diagn
; 9(4): 546-55, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17690214
10.
Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays.
J Mol Diagn
; 7(3): 337-45, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16049305
11.
B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases.
Am J Clin Pathol
; 144(2): 333-40, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26185320
12.
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
J Mol Diagn
; 15(2): 196-209, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23273604
13.
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia.
PLoS One
; 6(12): e28277, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22194822
14.
Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes.
Am J Clin Pathol
; 131(5): 663-70, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19369625
15.
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene.
Leuk Res
; 33(9): 1276-81, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19027161
16.
High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.
Blood
; 101(12): 4903-8, 2003 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12586616
Resultados
1 -
16
de 16
1
Próxima >
>>